跳至主要内容
临床试验/NCT01821651
NCT01821651Unknown不适用

Use of Standardized Diagnostic Imaging Data (Computertomography, Angiography, Echocardiography) for Image Fusion in the Hybrid Operating Room

University of Zurich2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
140
试验地点
2
主要终点
Radiation Dose (mSv) administered to each patient

研究概览

简要总结

Objectives:

Goal of the study is to investigate the potential benefit that transcatheter interventions such as Transcatheter Aortic Valve Implantation (TAVI), MitraClip, Left Atrial Appendage Closure and catheter Ablation can gain from multimodal image fusion techniques as they are available in the Hybrid suite.

Both the HeartNavigator and the EchoNav aim at decreasing the exposure to radiation and contrast agent, to shorten the operation time (efficacy), and to increase the quality of care (safety).

This pilot study aims at observing these aims on a small patient population and a control group.

Number of Subjects:

140 patients total in 6 groups:

  • MitraClip, Left Atrial Appendage Closure or catheter Ablation with EchoNav (20, lead-in stage).
  • MitraClip randomized with EchoNav (25), MitraClip randomized without EchoNav (25).
  • TAVI with HeartNavigator lead in (10)
  • TAVI randomized with HeartNavigator (30), TAVI randomized without HeartNavigator (30).

详细描述

Medical Device:

HeartNavigator: System for preoperative image-based assessment of aortic root geometry, planning of transcatheter aortic valve implantation, and intraoperative C-Arm control.

EchoNav: System for intraoperative registration of 3D Echo images with X-ray fluoroscopy images.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Radiation Dose (mSv) administered to each patient

时间窗: Day of intervention (day 1)

At the end of the procedure the recorded radiation-dose is assessed.

次要结局

  • Duration of the intervention (minutes)(Day of intervention (day 1))
  • Contrast agent dose (ml)(Day of intervention (day 1))
  • Increased quality of care (EchoNav group)(Discharge: 1 to 5 days after intervention)
  • Degree of Mitral Regurgitation (EchoNav group)(Discharge: 1 to 5 days after intervention)
  • Postinterventional transvalvular gradient(Up to 7 days after intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Use of Standardized Diagnostic Imaging Data for... | 临床试验